We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
Out of stock
This item is currently unavailable
Out of stock for 8 days. Get on the list — one email the moment it's back.
Out of stock 8 days
The 2025-2030 World Outlook for Fecal Occult Blood Tests for In-Vitro Colorectal Cancer Screenings
One email. No newsletter. No nudges.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
No price data yet
Price history will appear here once data is collected from Amazon.
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
↑ Price chart
when this has been cheap or pricey
when this has been cheap or pricey
↑ Forecast
where the price is heading next
where the price is heading next
↓ Statistics
all-time high & low, recent range
all-time high & low, recent range
↑ Price alert
name your number, we'll email you
name your number, we'll email you
Price Distribution
No price data available for histogram
Description
This study covers the world outlook for fecal occult blood tests for in-vitro colorectal cancer screenings across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of fecal occult blood tests for in-vitro colorectal cancer screenings as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Abbott Laboratories, Alere, Beckman Coulter, Clinical Genomics Technologies Pty, EIKEN Chemical Company, Epigenomics, Exact Sciences, Hemosure, Novigenix, Quidel Corporation, and Sysmex Corporation. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).
Product Specifications
- Format
- paperback
- ASIN
- B0CZ2M8W32
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 03 March 2024
- Listed Since
- 30 April 2024
Similar Products You Might Like
97% match
The 2023 Report on In-Vitro Colorectal Cancer Screening Tests: World Market Segmentation by City
£795.00
16 Aug 2026
97% match
The 2023-2028 World Outlook for Colorectal Cancer Drugs
£795.00
06 Sep 2026
97% match
The 2023-2028 Outlook for In Vitro Colorectal Cancer Testing for US Zip Codes
£490.00
03 Oct 2026
97% match
Colorectal Cancer - Diagnosis, Screening and Management
IntechOpen
£118.98
24 Sep 2026
96% match
Colorectal Cancer Screening, An Issue of Gastrointestinal Endoscopy Clinics (Volume 36-4) (The Clinics: Internal Medicine, Volume 36-4)
Elsevier
£92.99
09 Oct 2026
96% match
Multidisciplinary Treatment of Colorectal Cancer: Staging – Treatment – Pathology – Palliation
Springer
£79.70
30 Sep 2026
96% match
Molecular Mechanisms and Therapies of Colorectal Cancer 2.0
£52.81
17 Sep 2026
96% match
Screening for Colorectal Cancer with Colonoscopy - IntechOpen
IntechOpen
£119.00
17 Oct 2026
96% match
Colorectal Disorders and Diseases: An Infographic Guide
Elsevier
£100.36
09 Sep 2026
96% match
Colorectal Cancer Diagnosis: Advancements and Applications
CRC Press
£91.47
24 Sep 2026
96% match
Recent Understanding of Colorectal Cancer Treatment
IntechOpen
£114.00
23 Sep 2026
96% match
Academic Press Colorectal Cancer Treatment Resistance Book
Elsevier
£118.47
02 Oct 2026
96% match
Advances in Diagnosis and Therapy of Colorectal Carcinoma
IntechOpen
£119.00
23 Sep 2026
96% match
Timely Diagnosis of Colorectal Cancer
Springer
£99.89
24 Sep 2026
96% match
The 2025-2030 World Outlook for Ulcerative Proctitis
Price unavailable
96% match
Encyclopedia of Colorectal Cancer: Volume III (Epidemiology, Psychology and Nutrition): 3
Hayle Medical
£47.00
07 Sep 2026
96% match
The 2023-2028 Outlook for Ulcerative Proctitis in the United States
£520.00
12 Sep 2026
96% match
A Colorectal Cancer Screening Programme in Penang, Malaysia
LAP Lambert Academic Publishing
£49.00
06 Sep 2026
96% match
Gut Microbiota and Postbiotics for Colorectal Cancer - Humana
Humana
£147.14
20 Oct 2026
96% match
Signal Transducing Molecules and Colorectal Cancer - Kashmir Scenario: The Genetic Alterations of the Signal Transducing Molecules and their role in ... of Colorectal Cancer in Kashmir Valley
LAP Lambert Academic Publishing
£68.00
24 Sep 2026
96% match
Contemporary Issues in Colorectal Surgical Practice
IntechOpen
£119.00
24 Sep 2026
96% match
Pathogenesis, Diagnosis and Management of Colorectal Cancer
Foster Academics
£69.64
24 Sep 2026
95% match
Current Topics in Colorectal Surgery
IntechOpen
£114.00
24 Sep 2026
95% match
Encyclopedia of Colorectal Cancer: Volume II (Cell and Molecular Biology): 2
Hayle Medical
£46.98
20 Sep 2026